Nature Communications (Mar 2022)
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
Abstract
Loss of the tumour suppressor gene PTEN leads to the activation of pro-tumourigenic signalling pathways. Here, the authors analyse sequencing data from a large cohort of colorectal cancer patients harbouring PTEN mutations and identify distinct patterns of associations with genomic and clinical features.